ERNA Earnings Ernexa Therapeutics Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–38 of 38
| Q2 2026 | 2026-06-30 | -3.40 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | -6.95 | 2026-05-11 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 20.70 | 2026-03-13 | 10-K |
| FY 2025 | 2025-12-31 | -56.00 | 2026-03-13 | 10-K |
| Q3 2025 | 2025-09-30 | -3.75 | 2025-11-07 | 10-Q |
| Q2 2025 | 2025-06-30 | -15.19 | 2025-08-13 | 10-Q |
| Q1 2025 | 2025-03-31 | -57.76 | 2025-05-07 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 1463.25 | 2025-03-12 | 10-K |
| FY 2024 | 2024-12-31 | -1224.00 | 2025-03-12 | 10-K |
| Q3 2024 | 2024-09-30 | -1842.50 | 2024-11-12 | 10-Q |
| Q2 2024 | 2024-06-30 | -383.50 | 2024-08-13 | 10-Q |
| Q1 2024 | 2024-03-31 | -461.25 | 2024-05-14 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -427.50 | 2024-03-14 | 10-K |
| FY 2023 | 2023-12-31 | -1530.00 | 2024-03-14 | 10-K |
| Q3 2023 | 2023-09-30 | -386.25 | 2023-11-13 | 10-Q |
| Q2 2023 | 2023-06-30 | -318.75 | 2023-08-11 | 10-Q |
| Q1 2023 | 2023-03-31 | -397.50 | 2023-05-11 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -341.25 | 2023-03-20 | 10-K |
| FY 2022 | 2022-12-31 | -3022.50 | 2023-03-20 | 10-K |
| Q3 2022 | 2022-09-30 | -933.75 | 2022-11-14 | 10-Q |
| Q2 2022 | 2022-06-30 | -435.00 | 2022-08-11 | 10-Q |
| Q1 2022 | 2022-03-31 | -1312.50 | 2022-07-01 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | -8126.25 | 2022-04-15 | 10-K |
| FY 2021 | 2021-12-31 | -21228.75 | 2022-04-15 | 10-K |
| Q3 2021 | 2021-09-30 | -12761.25 | 2021-11-12 | 10-Q |
| Q2 2021 | 2021-06-30 | -90.00 | 2021-08-13 | 10-Q |
| Q1 2021 | 2021-03-31 | -251.25 | 2021-05-17 | 10-Q |
| Q4 2020 (derived) | 2020-12-31 | -10432.50 | — | — |
| FY 2020 | 2020-12-31 | -11325.00 | — | — |
| Q3 2020 | 2020-09-30 | -825.00 | — | — |
| Q2 2020 | 2020-06-30 | -45.00 | — | — |
| Q1 2020 | 2020-03-31 | -22.50 | — | — |
| Q3 2018 | 2018-09-30 | 30.00 | 2018-11-09 | 10-Q |
| Q3 2017 | 2017-09-30 | -26.25 | — | — |
| Q3 2013 | 2013-09-30 | 0.00 | 2013-11-14 | 10-Q |
| Q3 2012 | 2012-09-30 | 0.00 | 2012-11-09 | 10-Q |
| Q3 2011 | 2011-09-30 | -3.75 | 2011-11-14 | 10-Q |
| Q3 2010 | 2010-09-30 | 0.00 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.